EDGAR Filing Documents for 0001564590-18-004745

Form 8-K - Current report:

SEC Accession No. 0001564590-18-004745

Filing Date

2018-03-07

Accepted

2018-03-07 16:47:14

Documents

Period of Report

2018-03-07

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ctmx-8k_20180307.htm	8-K	32495
2	EX-99.1	ctmx-ex991_6.htm	EX-99.1	315171
	Complete submission text file	0001564590-18-004745.txt		348799

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 18673874
SIC: 2834 Pharmaceutical Preparations